Original articlesLung cancerRandomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
Lung cancer
Under an Elsevier user license
open archive
Keywords
cisplatin
gemcitabine
HER2
non-small-cell lung cancer
trastuzumab
Cited by (0)
Copyright © 2004 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.